Filing Details

Accession Number:
0001140361-16-085412
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-08 16:44:56
Reporting Period:
2016-11-04
Filing Date:
2016-11-08
Accepted Time:
2016-11-08 16:44:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1347613 Synergy Pharmaceuticals Inc. SGYP () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1035674 Paulson & Co. Inc. 1251 Avenue Of The Americas
New York NY 10020
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value Of $.0001 Disposition 2016-11-04 140,000 $4.24 24,088,655 No 4 S Indirect By Managed Funds and Accounts
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Managed Funds and Accounts
Footnotes
  1. Paulson & Co. Inc. ("Paulson") is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds") and certain separately managed accounts (the "Separately Managed Accounts"). John Paulson is the controlling person of Paulson. All securities reported on this Form 4 are owned by the Funds or held in the Separately Managed Accounts.
  2. Each of Paulson and John Paulson may be deemed to indirectly beneficially own the securities directly owned by the Funds or held in the Separately Managed Accounts. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4.